SCHEMBL3116284

SCHEMBL3116284

CCCCn1c(=O)n(CCCCN(C)S(=O)(=O)c2ccccc2)c(=O)c2[nH]c(Cl)nc21

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ADORA2B P29275 5/20 0.47
▸ ADORA2A P29274 4/20 0.47
▸ ADORA1 P30542 3/20 0.47
▸ KDM4E B2RXH2 1/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ ADORA3 P0DMS8 1/20 0.45
▸ PDE5A O76074 1/20 0.43
▸ PDE4A P27815 1/20 0.43
▸ PDE4B Q07343 1/20 0.43
▸ PDE4C Q08493 1/20 0.43
▸ PDE4D Q08499 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3119443 0.80 SIRT1 (0.54) ADORA2BADORA2AADORA1ADORA3PDE4A
SCHEMBL13248155 0.80 ADORA1 (0.51) ADORA2BADORA2AADORA1KDM4EMEN1
SCHEMBL3121854 0.80 ADORA1 (0.51) ADORA2BADORA2AADORA1KDM4EMEN1
SCHEMBL13247926 0.79 ADORA2B (0.53) ADORA2BADORA2AADORA1ADORA3PDE4A
SCHEMBL13247927 0.79 ADORA2B (0.53) ADORA2BADORA2AADORA1ADORA3PDE4A
SCHEMBL7031457 0.79 SIRT1 (0.55) ADORA2BADORA2AADORA1ADORA3PDE4A
SCHEMBL3106241 0.79 ADORA2B (0.58) ADORA2BADORA2AADORA1KDM4EMEN1
SCHEMBL3620246 0.79 SIRT1 (0.61) ADORA2BADORA2AADORA1KDM4EMEN1
SCHEMBL3611280 0.78 ADORA2A (0.60) ADORA2BADORA2AADORA1KDM4EMEN1
SCHEMBL3114042 0.78 PDE4A (0.55) ADORA2BADORA2AADORA1ADORA3PDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100179128-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS SMITHKLINE BEECHAM CORPORATION 2010-07-15 — — US disclosed
US-20100179128-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS SMITHKLINE BEECHAM CORPORATION 2010-07-15 — — US disclosed
US-20100179128-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS SMITHKLINE BEECHAM CORPORATION 2010-07-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179128-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS XDH, GPR84, GPR88 ADORA2B 111/4885ADORA2A 17/4885ADORA1 32/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback